已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Malignant Glioma

胶质瘤 医学 疾病 脑瘤 模式 病理 放射治疗 肿瘤科 内科学 癌症研究 社会科学 社会学
作者
Linda M. Wang,Zachary Englander,M. L. Miller,Jeffrey N. Bruce
出处
期刊:Advances in Experimental Medicine and Biology 卷期号:: 1-30 被引量:31
标识
DOI:10.1007/978-3-031-23705-8_1
摘要

This chapter provides a comprehensive overview of malignant gliomasMalignant glioma, the most common primary brain tumorPrimary brain tumor in adults. These tumors are varied in their cellular origin, geneticGenetics profile, and morphologyMorphology under the microscopeMicroscope, but together they share some of the most dismal prognoses of all neoplasmsNeoplasm in the body. Although there is currently no cure for malignant gliomaMalignant glioma, persistent efforts to improve outcomes in patients with these tumors have led to modest increases in survivalSurvival, and researchers worldwide continue to strive toward a deeper understanding of the factors that influence gliomaGliomas development and response to treatment. In addition to well-established epidemiology, clinical manifestations, and common histopathologic and radiologic features of malignant gliomasMalignant glioma, this section considers recent advances in molecular biologyMolecular biology that have led to a more nuanced understanding of the geneticGenetics changes that characterize the different types of malignant gliomaMalignant glioma, as well as their implications for treatment. Beyond the traditional classification of malignant gliomasMalignant glioma based on histopathological features, this chapter incorporates the World Health Organization’sWorld Health Organization (WHO) 2016 criteria for the classification of brain tumorsBrain tumor, with special focus on disease-defining geneticGenetics alterations and newly established subcategories of malignant gliomaMalignant glioma that were previously unidentifiable based on microscopic examination alone. Traditional therapeutic modalities that form the cornerstone of treatment for malignant gliomaMalignant glioma, such as aggressive surgical resectionSurgical resection followed by adjuvantAdjuvant chemotherapyChemotherapy and radiation therapyRadiation therapy, and the studies that support their efficacy are reviewed in detail. This provides a foundation for additional discussion of novel therapeutic methods such as immunotherapyImmunotherapy and convection-enhanced deliveryConvection-enhanced delivery (CED), as well as new techniques for enhancing extent of resectionExtent of resection (EOR) such as fluorescence-guided surgeryFluorescence-guided surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
年轻水壶完成签到 ,获得积分10
1秒前
dogontree发布了新的文献求助10
1秒前
2秒前
Kiki完成签到 ,获得积分10
2秒前
3秒前
3秒前
香蕉觅云应助半截神经病采纳,获得10
5秒前
XU发布了新的文献求助30
5秒前
Hastur00完成签到 ,获得积分10
5秒前
小羿完成签到,获得积分10
7秒前
skskysky完成签到 ,获得积分10
7秒前
Xuhao23发布了新的文献求助10
7秒前
10秒前
Dakota完成签到,获得积分10
11秒前
12秒前
13秒前
科研通AI2S应助勇敢牛牛采纳,获得10
13秒前
深情芷完成签到,获得积分10
13秒前
cui完成签到 ,获得积分10
14秒前
李健应助科研通管家采纳,获得10
14秒前
14秒前
wanci应助科研通管家采纳,获得10
14秒前
ccm应助科研通管家采纳,获得10
14秒前
情怀应助科研通管家采纳,获得10
14秒前
科研通AI2S应助科研通管家采纳,获得10
14秒前
14秒前
浅尝离白应助欣欣子采纳,获得30
14秒前
14秒前
Xuhao23完成签到,获得积分10
15秒前
大模型应助神勇麦片采纳,获得10
17秒前
柔弱的无心完成签到 ,获得积分10
17秒前
ji发布了新的文献求助10
18秒前
18秒前
chrissylaiiii发布了新的文献求助10
19秒前
DrLee完成签到,获得积分10
19秒前
共享精神应助醒醒采纳,获得10
20秒前
自由的雪完成签到 ,获得积分10
22秒前
24秒前
缪甲烷完成签到,获得积分10
25秒前
25秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Pearson Edxecel IGCSE English Language B 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142425
求助须知:如何正确求助?哪些是违规求助? 2793350
关于积分的说明 7806409
捐赠科研通 2449622
什么是DOI,文献DOI怎么找? 1303363
科研通“疑难数据库(出版商)”最低求助积分说明 626850
版权声明 601309